The nurse is providing discharge teaching to a client prescribed ertugliflozin (Steglatro). Which instruction would be included?

Rationale: A. Ertugliflozin is an SGLT2 inhibitor, which increases glucose excretion in the urine and naturally increases urinary output (polyuria). Fluid restriction is not recommended, as it can worsen dehydration, hypotension, or electrolyte imbalance. Adequate hydration is important. B. Ertugliflozin typically causes mild reductions in blood pressure due to osmotic diuresis and natriuresis. Hypertension is not a common adverse effect. C. SGLT2 inhibitors increase urinary glucose excretion, which creates an environment conducive to genital fungal infections (candidiasis). Patients should be taught to: Monitor for itching, discharge, redness, or discomfort, report symptoms promptly and practice good hygiene to help prevent infections D. SGLT2 inhibitors may actually cause mild diuresis and volume loss, not fluid retention. Swelling or edema is not expected and should be evaluated if it occurs, as it may indicate another condition.